 |
|
|
| |
Predictors of HIV Pre-Exposure Prophylaxis Preferences Using the Health Belief Model: Twice-Yearly Subcutaneous Lenacapavir Versus Daily Pills in the PURPOSE 1 Trial
|
| |
| |
13th International AIDS Society (IAS) Conference on HIV Science; July 13–17, 2025; Kigali, Rwanda
Leila E Mansoor1,
|
| |
|
|
|
|
|
